Concepedia

Steven Sugarman

SS

Statistics

Publications

15

Citations

1.6K

H-Index

14

Active since

1999

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

State University of New York

Stony Brook University

Georgetown University

Dana-Farber Cancer Institute

Steven Sugarman is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

1999–2017

15

Publications

15

HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab

Shanu Modi, Alison Stopeck, Hannah Linden et al. · Clinical Cancer Research · 2011 · 424 citations

, , +16

Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer

Anthony W. Tolcher, Steven Sugarman, Karen A. Gelmon et al. · Journal of Clinical Oncology · 1999 · 268 citations

, , +17

Randomized, Controlled Trial of Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients

Gary Deng, Andrew J. Vickers, K. Simon Yeung et al. · Journal of Clinical Oncology · 2007 · 191 citations · Full text

, , +10

Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

Patrick G. Morris, Carol Chen, Richard M. Steingart et al. · Clinical Cancer Research · 2011 · 141 citations · Full text

, , +15

A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer

Komal Jhaveri, Sarat Chandarlapaty, Diana Lake et al. · Clinical Breast Cancer · 2014 · 102 citations

, , +11

1–5 of 15